Liquid Instruments Partners with Scanfil to Onshore Moku Platform Production in Australia

Scanfil and Liquid Instruments have signed a manufacturing outsourcing agreement for Scanfil’s Melbourne plant in Australia. This agreement support...

June 26, 2025 | Thursday | News
Noxopharm Advances HERACLES Trial with Rapid Recruitment for First-in-Human SOF-SKN™ Study in Autoimmune Diseases

Clinical-stage biotech company Noxopharm Limited (ASX:NOX) is pleased to announce that recruitment activities are progressing rapidly and on sche...

June 25, 2025 | Wednesday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Incannex and Mind Medicine Australia Launch Joint Venture to Open Psychedelic Therapies Clinic in Melbourne

Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combi...

June 18, 2025 | Wednesday | News
Forging the Future of Biomanufacturing: How VVMF and Cytiva Are Elevating Australia’s Global Role

As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—espec...

June 05, 2025 | Thursday | Interaction
Avance Clinical Empowers US Biotechs With GlobalReady Program Amid Regulatory Uncertainty at Home

As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-p...

May 27, 2025 | Tuesday | News
Eli Lilly’s Kisunla™ (donanemab) Receives Marketing Authorization in Australia for Early Alzheimer’s Treatment

 Eli Lilly and Company  announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for Kisunla (d...

May 22, 2025 | Thursday | News
Microba’s MetaXplore™ GI Plus Demonstrates Clinical Impact in Over 70% of Patients With Chronic Gut Symptoms

Microba Life Sciences Limited, a precision microbiome company,  announces preliminary results from the analysis of over 4,600 MetaXplore™ GI P...

May 16, 2025 | Friday | News
Australia’s Immutep Achieves 17.6-Month Survival with Chemo-Free Immunotherapy in Head and Neck Cancer

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck cancer patients with PD-L1 CPS...

May 06, 2025 | Tuesday | News
Antengene to Present Promising Clinical Data on ATG-037 and ATG-008 at 2025 ASCO Annual Meeting

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commer...

April 24, 2025 | Thursday | News
Sanofi’s mRNA Chlamydia Vaccine Candidate Receives Fast Track Designation from FDA

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. ...

March 28, 2025 | Friday | News
bioLytical Launches INSTI® Multiplex HIV-1/2 Syphilis Antibody Test in Australia for Rapid Diagnosis

RICHMOND, British Columbia, bioLytical Laboratories Inc. (“bioLytical”), a global leader in rapid infectious disease diagnostics, announces the...

March 20, 2025 | Thursday | News
Mozart Therapeutics Completes Successful Phase 1a Study of MTX-101 in Healthy Adults

 Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, announce the successful completion of thei...

March 19, 2025 | Wednesday | News
Telix Pharmaceuticals' Illuccix® Receives Full ANVISA Approval for Prostate Cancer Imaging in Brazil

Telix Pharmaceuticals Limited announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approve...

March 19, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close